2023-12-07 08:02:08 ET
More on Regeneron Pharmaceuticals
- Regeneron Pharmaceuticals, Inc. (REGN) Piper Sandler 35th Annual Healthcare Conference (Transcript)
- Regeneron Pharmaceuticals, Inc. (REGN) Presents at Jefferies London Healthcare Conference (Transcript)
- Regeneron Pharmaceuticals, Inc. (REGN) Presents at Truist Securities BioPharma Symposium (Transcript)
- Replimune shares crash as skin cancer candidate fails trial
- Sanofi reports positive Phase 3 data on Dupixent for COPD
For further details see:
Regeneron lifts complete remission in trial for multiple myeloma candidate